First oral TRT option under FDA review PDUFA goal date of June 28, 2016 product targeting ~$2.0 Billion established US market http://files.shareholder.com/downloads/AMDA-2BVSIV/1840697421x0x881108/9521E3DD-F9C3-4529-B9D3-74F6ACF78801/March_Corp_Presentation_031016-mvp.pdf